Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Amlodipine products are in shortage in Canada (4 of 48 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A calcium channel blocker used to lower blood pressure and treat chest pain (angina).
Products affected
4 / 48
In shortage since
May 21, 2020
Reports on file
124
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TARO-AMLODIPINE
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02321858 · since Sep 1, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TARO-AMLODIPINE
10MG · TABLET · SUN PHARMA CANADA INC
DIN 02321866 · since Sep 1, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
SEPTA-AMLODIPINE
5MG · TABLET · SEPTA PHARMACEUTICALS INC
DIN 02357712 · since May 21, 2020, no end estimate · Supply issues
Active shortage
SEPTA-AMLODIPINE
10MG · TABLET · SEPTA PHARMACEUTICALS INC
DIN 02357720 · since May 21, 2020, no end estimate · Supply issues
Resolved
JAMP-AMLODIPINE
10MG · TABLET · JAMP PHARMA CORPORATION
DIN 02357208 · ended Apr 10, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ AMLODIPINE
10MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02284391 · ended Jun 30, 2025 · Demand increase for the drug.
reversed
TEVA-AMLODIPINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02297493
reversed
TEVA-AMLODIPINE
5MG · TABLET · TEVA CANADA LIMITED
DIN 02297485
Resolved
AURO-AMLODIPINE
5MG · TABLET · AURO PHARMA INC
DIN 02397072 · ended Jun 1, 2025 · Demand increase for the drug.
Resolved
ACH-AMLODIPINE
2.5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02419556 · ended Aug 9, 2024 · Disruption of the manufacture of the drug.
Resolved
SANDOZ AMLODIPINE
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02284383 · ended Jul 15, 2024 · Disruption of the manufacture of the drug.
Resolved
SANDOZ AMLODIPINE
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02284383 · ended Jun 3, 2024 · Requirements related to complying with good manufacturing practices.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Amlodipine is currently affected by 4 active shortage reports filed with Health Canada by SUN PHARMA CANADA INC, SEPTA PHARMACEUTICALS INC.
The reported causes are: disruption of the manufacture of the drug; supply issues. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Amlodipine is classified under “SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.” (ATC C08CA).
Recent changes
No changes recorded yet.
Common questions
What is Amlodipine used for?
A calcium channel blocker used to lower blood pressure and treat chest pain (angina).
When will Amlodipine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Amlodipine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.